Get startedLog in
    Picture of Madrigal Pharmaceuticals logo

    MDGL — Madrigal Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapMomentum Trap
    All News

    Brief: Madrigal Expands Its Mash Pipeline With Exclusive Global License Agreement For Ervogastat

    Picture of Madrigal Pharmaceuticals logoMadrigal Pharmaceuticals
    09/01/2026 13:52
    Jan 9 (Reuters) - Madrigal Pharmaceuticals Inc MDGL.O:

MADRIGAL EXPANDS ITS MASH PIPELINE WITH EXCLUSIVE GLOBAL LICENSE AGREEMENT FOR ERVOGASTAT, A PHASE 2 ORAL DGAT-2 INHIBITOR

MADRIGAL PHARMACEUTICALS INC - PFIZER RECEIVES $50 MILLION UPFRONT PAYMENT FROM MADRIGAL

MADRIGAL PHARMACEUTICALS INC - PLANS DRUG-TO-DRUG INTERACTION STUDY WITH REZDIFFRA

Source text: ID:nGNX3prnrn

Further company coverage: MDGL.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Madrigal Pharmaceuticals

    See all news